It was great to spend some time with Ric and the folks at Critical Mass to talk about guiding principles and the lessons learned from starting and growing a successful business.
Irvine, CA (PRWEB) September 16, 2015
Proove Biosciences, a commercial and research leader in Personalized Medicine, was recently featured on the local radio program, Critical Mass. Brian Meshkin, the founder and CEO of Proove Biosciences, was interviewed on September 2, 2015 by Richard Franzi on the application and success of his personalized medicine company.
Founded in 2009, Proove Biosciences is the commercial and research leader in the field of personalized medicine for the nation’s largest and most expensive health condition - pain. Over the past five and half years, Proove has experienced tremendous growth. Proove’s leading research has received awards and recognitions from leading medical societies such as the American Academy of Neurology, the American Society of Interventional Pain Physicians and others. Proove’s commercial growth has been equally impressive with profitability, rapid revenue growth, and over 200 employees. Proove Biosciences currently offers eight proprietary genetic tests and has a robust pipeline of new tests coming to market.
Proove CEO, Brian Meshkin, is a successful entrepreneur and biotechnology leader, having been recognized as an 2015 EY Entrepreneur of the Year Finalist in Orange County, a SmartCEO magazine Future 50 award winner the past two years, and numerous other awards. “It was great to spend some time with Ric and the folks at Critical Mass to talk about guiding principles and the lessons learned from starting and growing a successful business.”
A free podcast of the live radio show can be found at http://www.ceopeergroups.podbean.com.
About Proove Biosciences
Our Mission is to Change the Future of Medicine. Proove is the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could’ve ever prescribed medications without knowing how a patient would respond. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of personalized pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve outcomes – both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).